Join our email list to stay up to date on the latest Amyloidosis news.
This CME webinar will present introductory information on TTR amyloidosis. The targeted audience is primary care providers, in hopes that clarification of typical ATTR clinical scenarios will enable more prompt consideration of the diagnosis, and timely referral to appropriate clinicians expert in management of the disease to confirm the diagnosis and provide pharmacologic treatment.

At the completion of this course, the learner will be able to:

  • Recognize the pathophysiology of ATTR as a member of the protein-misfolding disorders.
  • Describe typical clinical presentations and red flags of ATTR as encountered in the primary care setting.
  • Identify with the non-invasive diagnosis of ATTR cardiomyopathy.
  • Explain the fundamentals of some currently available pharmacotherapies for ATTR.
*
*
*
*